Prepronociceptin (PPNOC)

Prepronociceptin is a neuropeptide precursor protein that is highly conserved across species and serves as the precursor to nociceptin (also called orphanin FQ), as well as other biologically active peptides[1][3]. The gene encoding prepronociceptin (PPNOC) shows strong structural similarity to the genes encoding other opioid peptide precursors such as preproenkephalin and preprodynorphin, pointing to an evolutionarily conserved family of neuropeptide precursors[1][3]. Prepronociceptin is primarily expressed in the central nervous system, specifically the brain and spinal cord, with minor expression in the ovary[1][3]. The most notable bioactive peptide derived from prepronociceptin is nociceptin, which is the endogenous ligand for the nociceptin receptor (NOP, also termed OPRL1 or OP4), a member of the opioid receptor family[2][3]. Nociceptin and its receptor have diverse roles in the modulation of pain, locomotor activity, feeding, anxiety, memory, and other CNS functions, but prepronociceptin itself is not the direct target of drugs—its processed peptides or the receptor are[2]. Prepronociceptin is sometimes confused as a "target" but it is more accurately described as a precursor molecule; the receptor it gives rise to via its processed peptide products is the relevant therapeutic target, not prepronociceptin itself[2][3]. **Summary of correct classification**: - *Prepronociceptin is a peptide precursor, not a receptor, enzyme, transporter, or classical therapeutic target—drugs do not target prepronociceptin directly, but rather its mature peptides or their cognate receptors.* - *The commonly targeted entity in research and therapy is the nociceptin receptor (NOP/OPRL1/OP4), not prepronociceptin.* **Note**: If a drug target is intended, you may be looking for “Nociceptin receptor” or “NOP receptor (OPRL1/OP4)” instead. Prepronociceptin itself is not a direct pharmacological target.

Other names

Prepronociceptin precursorPPNOCNociceptin precursorProorphanin FQ